Ray Dalio Biolife Solutions Inc Transaction History

Bridgewater Associates, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$14.64 - $26.7 $4,201 - $7,662	287 Added 0.46%	62,642 $1.43 Million
Q2 2022 Aug 11, 2022	BUY	$10.54 - $24.2 $66,665 - $153,065	6,325 Added 11.29%	62,355 $861,000
Q1 2022 May 13, 2022	BUY	$20.81 - $37.29 $271,736 - $486,932	13,058 Added 30.39%	56,030 $1.27 Million
Q4 2021 Feb 14, 2022	BUY	$32.99 - $58.55 $113,749 - $201,880	3,448 Added 8.72%	42,972 $1.6 Million
Q3 2021 Nov 12, 2021	SELL	$42.03 - $60.5 $104,906 - $151,008	-2,496 Reduced 5.94%	39,524 $1.67 Million
Q2 2021 Aug 13, 2021	BUY	$29.51 - $44.62 $1.24 Million - $1.87 Million	42,020 New	42,020 $1.87 Million

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.